<?xml version='1.0' encoding='utf-8'?>
<document id="12583007"><sentence text="Specific determination of unbound oxacillin in protein solution with cefoperazone by high-performance frontal analysis with chemiluminescence detection."><entity charOffset="34-43" id="DDI-PubMed.12583007.s1.e0" text="oxacillin" /><entity charOffset="69-81" id="DDI-PubMed.12583007.s1.e1" text="cefoperazone" /><pair ddi="false" e1="DDI-PubMed.12583007.s1.e0" e2="DDI-PubMed.12583007.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12583007.s1.e0" e2="DDI-PubMed.12583007.s1.e1" /></sentence><sentence text="Unbound oxacillin concentrations in human serum albumin (HSA) solutions in the presence or absence of cefoperazone were determined using high-performance frontal analysis coupled with chemiluminescence detection (HPFA-CL)"><entity charOffset="8-17" id="DDI-PubMed.12583007.s2.e0" text="oxacillin" /><entity charOffset="102-114" id="DDI-PubMed.12583007.s2.e1" text="cefoperazone" /><pair ddi="false" e1="DDI-PubMed.12583007.s2.e0" e2="DDI-PubMed.12583007.s2.e0" /><pair ddi="false" e1="DDI-PubMed.12583007.s2.e0" e2="DDI-PubMed.12583007.s2.e1" /></sentence><sentence text=" The HPFA was performed on an ISRP column with 67 mM potassium phosphate buffer of pH 7"><entity charOffset="53-72" id="DDI-PubMed.12583007.s3.e0" text="potassium phosphate" /></sentence><sentence text="4 and ionic strength of 0" /><sentence text="17 as the mobile phase" /><sentence text=" The luminol-H(2)O(2)-Co(2+) system was employed in the chemiluminescence detection"><entity charOffset="5-28" id="DDI-PubMed.12583007.s6.e0" text="luminol-H(2)O(2)-Co(2+)" /></sentence><sentence text=" The detection was highly specific for oxacillin in the presence of cefoperazone"><entity charOffset="39-48" id="DDI-PubMed.12583007.s7.e0" text="oxacillin" /><entity charOffset="68-80" id="DDI-PubMed.12583007.s7.e1" text="cefoperazone" /><pair ddi="false" e1="DDI-PubMed.12583007.s7.e0" e2="DDI-PubMed.12583007.s7.e0" /><pair ddi="false" e1="DDI-PubMed.12583007.s7.e0" e2="DDI-PubMed.12583007.s7.e1" /></sentence><sentence text=" Although both drugs in HSA solutions co-eluted in the same region in HPFA, cefoperazone did not interfere with the determination of unbound concentration of oxacillin"><entity charOffset="76-88" id="DDI-PubMed.12583007.s8.e0" text="cefoperazone" /><entity charOffset="158-167" id="DDI-PubMed.12583007.s8.e1" text="oxacillin" /><pair ddi="false" e1="DDI-PubMed.12583007.s8.e0" e2="DDI-PubMed.12583007.s8.e0" /><pair ddi="false" e1="DDI-PubMed.12583007.s8.e0" e2="DDI-PubMed.12583007.s8.e1" /></sentence><sentence text=" In the solution of 100 microM HSA and 11" /><sentence text="33 micro M oxacillin the bound percentage of oxacillin to HSA was estimated as 80"><entity charOffset="45-54" id="DDI-PubMed.12583007.s10.e0" text="oxacillin" /></sentence><sentence text="5%" /><sentence text=" Addition of 30" /><sentence text="98 micro M cefoperazone into the HSA-equilibrated solution produced little effect on the protein binding of oxacillin"><entity charOffset="11-23" id="DDI-PubMed.12583007.s13.e0" text="cefoperazone" /><entity charOffset="108-117" id="DDI-PubMed.12583007.s13.e1" text="oxacillin" /><pair ddi="false" e1="DDI-PubMed.12583007.s13.e0" e2="DDI-PubMed.12583007.s13.e0" /><pair ddi="false" e1="DDI-PubMed.12583007.s13.e0" e2="DDI-PubMed.12583007.s13.e1" /></sentence><sentence text=" In the presence of 154" /><sentence text="9 micro M cefoperazone, however, the bound percentage of oxacillin was significantly reduced"><entity charOffset="10-22" id="DDI-PubMed.12583007.s15.e0" text="cefoperazone" /><entity charOffset="57-66" id="DDI-PubMed.12583007.s15.e1" text="oxacillin" /><pair ddi="false" e1="DDI-PubMed.12583007.s15.e0" e2="DDI-PubMed.12583007.s15.e0" /><pair ddi="false" e1="DDI-PubMed.12583007.s15.e0" e2="DDI-PubMed.12583007.s15.e1" /></sentence><sentence text=" This specific method could be applied to the investigation of drug-drug interaction in protein binding" /><sentence text="" /></document>